Skip to content
Screener

Cullinan Therapeutics, Inc. CGEM Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.75Beat by $0.09
Revenue estimate$3.7M
EPS estimate-$0.84

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$2.0M
EPS estimate-$0.84

Financials

Q1 2026

Income statement

See full
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$860.08M+94.2%
Enterprise value$787.38M+114%

Returns & leverage

See full
Current ratio10.3×-1.3×

FAQ

When did Cullinan Therapeutics, Inc. report Q1 2026 earnings?
Cullinan Therapeutics, Inc. (CGEM) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Cullinan Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Cullinan Therapeutics, Inc. reported eps of $-0.75 for Q1 2026.
Did Cullinan Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.84 by $0.09.
How did Cullinan Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 1.4% from $-0.74.
Where can I find Cullinan Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-210290) and the 10-Q periodic report (0001193125-26-210304) directly on SEC EDGAR. The filing index links above go to sec.gov.